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Abstract
Background: Distant metastases from colon cancer spread most frequently to the liver and the lung. Risk factors
include positive lymph nodes and high grade tumors. Isolated metastases to the appendicular skeleton are very
rare, particularly in the absence of identifiable risk factors.
Case report: The patient was a 55 year old male with no previous personal or family history of colon cancer. Routine
screening revealed a sigmoid adenocarcinoma. He underwent resection with primary anastomosis and was found to
have Stage IIA colon cancer. He declined chemotherapy as part of a clinical trial, and eight months later was found
to have an isolated metastasis in his right scapula. This was treated medically, but grew to 12 × 15 cm. The patient
underwent a curative forequarter amputation and is now more than four years from his original colon surgery.
Discussion: Stage IIA colon cancers are associated with a high five year survival rate, and chemotherapy is not
automatically given. If metastases occur, they are likely to arise from local recurrence or follow lymphatic
dissemination to the liver or lungs. Isolated skeletal metastases are quite rare and are usually confined to the axial
skeleton. To our knowledge, this is the first reported case of an isolated scapular metastasis in a patient with node
negative disease. The decision to treat the recurrence with radiation and chemotherapy did not reduce the tumor,
and a forequarter amputation was eventually required.
Conclusion: This case highlights the importance of adequately analyzing the stage of colon cancer and offering
appropriate treatment. Equally important is the early involvement of a surgeon in discussing the timing of the
treatment for recurrence. Perhaps if the patient had received chemotherapy or earlier resection, he could have
been spared the forequarter amputation. The physician must also be aware of the remote possibility of an unusual
presentation of metastasis in order to pursue timely work up.
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Background
Distant metastases from colon cancer spread most fre-
quently to the liver and the lung. Risk factors include
high grade tumors and lymph node involvement. Iso-
lated metastases to the appendicular skeleton are very
rare, particularly in the absence of identifiable risk
factors.
Case report
The patient was a 55 year old male with iron deficiency
anemia and no family history of colon cancer. His work
up included an esophagogastroduodenoscopy and colo-
noscopy, which revealed a sigmoid adenocarcinoma and
a questionable mass in the cecum. A computed tomo-
graphy (CT) scan of his chest, abdomen and pelvis did
not indicate additional disease. His carcinoembryonic
antigen (CEA) level was 1.6 ng/mL. In early 2007, the
patient underwent a sigmoid resection and right hemi-
colectomy with primary anastomosis. The final pathol-
ogy confirmed a diagnosis of T3N0M0 adenocarcinoma
with seven negative lymph nodes in the sigmoid colon
and a benign polyp in the cecum.
After establishing the diagnosis of stage IIA sigmoid
cancer, the patient was offered chemotherapy as part of
a clinical trial, but declined. At three months he noticed
right shoulder pain, and at five months he noticed a
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small, golf-ball sized mass. Eight months after his sur-
gery, he presented to his primary care physician who
immediately referred him to an orthopedic surgeon. His
initial magnetic resonance imaging (MRI) demonstrated
a 10 × 10 cm mass originating from his right scapula. A
core needle biopsy was performed, revealing adenocarci-
noma consistent with a colorectal primary. His CEA
level at this point was 1480 ng/mL. A hybrid CT/PET
(positron emission tomography) scan as well as addi-
tional lab work did not identify any additional focus of
metastasis.
The patient and his doctors elected to treat the metas-
tasis with chemotherapy and radiation. He was started
on radiotherapy with radiosensitization using Capecita-
bine followed by chemotherapy with FOLFOX (infu-
sional 5-fluorouracil, leucovorin, and oxaliplatin) and
Bevacizumab. After 12 cycles, the patient developed sig-
nificant side effects, and the regimen was changed to
FOLFIRI (infusional 5-fluorouracil, leucovorin, and
irinotecan).
Serial CT and MRI scans during the chemotherapy
demonstrated increasing size of the mass. Twenty
months after his initial surgery, the patient noticed a
decline in his arm function while his pain continued to
increase. At this point, his MRI showed a 12 × 15 cm
mass, his CEA level was 484 ng/mL and his alkaline
phosphatase was 183 IU/L. Another hybrid CT/PET
scan in late 2008 (Figure 1) again demonstrated no addi-
tional focus of metastasis, but did show close proximity
of the tumor to the chest wall.
The patient’s oncologist referred him to our center,
and forequarter amputation with possible chest wall
reconstruction was recommended. A month after the
CT/PET scan, the surgical oncologist removed the
patient’s right arm and scapula, but was able to avoid
resecting the chest wall (Figure 2). A plastic surgeon
provided reconstruction using a musculocutaneous flap.
Final pathology demonstrated negative margins. The
patient healed well without incident and is working with
physical therapy. Six months following the surgery, his
CEA level was 1.6 ng/mL and has remained low on sub-
sequent follow-up visits. The most recent information is
from mid-2011, where the CEA level was determined to
be 1.5 ng/mL, and a CT was negative for any evidence
of metastasis.
Discussion
Colorectal cancer is the third most common cause of can-
cer in men and women in the United States [1]. Screening
for colon cancer is an important factor in decreasing the
morbidity and mortality of the disease, given the much
higher survival rate for earlier stage tumors versus more
advanced disease. Stage IIA colon cancer (T3N0M0
lesions) has a high five year survival rate of 85% as
reported by the SEERS database [2]. Given the excellent
survival rate based on surgery alone, medical treatment of
Stage II colon cancers remains somewhat controversial.
The National Comprehensive Cancer Network (NCCN)
has examined several studies and currently recommends
either chemotherapy, enrollment in a clinical trial, or close
observation after adequate surgical excision for Stage IIA
cancers [3]. The NCCN also identified several risk factors
that may help determine which patients would benefit
most from the addition of chemotherapy. These include
high grade tumor characteristics on histology, perforation
or obstruction at the time of presentation, lymphovascular
invasion, or fewer than 12 lymph nodes removed during
resection. A single risk factor was identified in this patient
in that only seven nodes were resected, but he declined
initial chemotherapy.
Skeletal metastases with colon cancer occur in 5-10%
of cases and usually after widespread metastatic disease
[4-8]. The usual pattern of metastasis is through the
liver and the lungs, thus making isolated skeletal metas-
tases even more uncommon, at 1-2% [4,6]. The most
likely route for skeletal seeding is through Batson’s
Figure 1 Preoperative CT scan demonstrating large scapular
mass.
Figure 2 Post-operative CT scan showing the intact chest wall
and removal of tumor.
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plexus, a valveless system of veins draining to the ver-
tebral column, making it the most common site for ske-
letal metastasis. Other frequent sites include the skull,
pelvis, femur and humerus [4,9-11]. Unusual sites have
been reported in the literature, but to our knowledge,
this is the first report of an isolated scapular metastasis
in a patient with negative lymph nodes.
Successful treatment of scapular tumors correlates
with complete resection [12], and served as the impetus
for surgical selection in this case. While a forequarter
amputation is associated with significant cosmetic, func-
tional, and psychological impacts, it is a valuable proce-
dure to achieve negative margins in advanced tumors
and may aid in significant palliation [13]. Historically
there are two well defined techniques to consider when
performing a forequarter amputation. These include the
anterior (Berger) approach and the posterior (Little-
wood) approach. Our technique consisted of a combined
anterior and posterior approach as described by Ferrario
et al. [14], allowing complete dissection of bone and soft
tissue prior to transection of the subclavian vessels. This
approach provides circumferential access to the vessels
and brachial plexus prior to ligation and significantly
reduces the risk of uncontrolled bleeding as well as
allowing for a greater proximal margin.
Perhaps if the tumor had been discovered earlier, it
may have been amenable to a limb-sparing scapulectomy.
A complete scapulectomy or Tikhoff-Linberg procedure
is associated with a significant complication rate, but
does provide an acceptable treatment for shoulder can-
cers if negative margins are achieved [15]. Recovery from
scapulectomy involves therapy and psychological adjust-
ment, but has an overall favorable report [16]. A limb-
sparing surgery was not adequate in this case according
to published guidelines, given the extensive size of the
tumor and possible chest wall invasion which would have
made achieving an R0 resection unlikely [17,18].
Difficulty often arises in determining optimal timing
and course of treatment for unusual metastases. A
multi-disciplinary team reviewed this patient’s case and
agreed to first pursue chemotherapy and radiation
rather than resection. It is possible that the patient’s
upper extremity could have been spared had the resec-
tion occurred earlier. While chemotherapy does remain
a mainstay treatment of metastatic colon cancer, if exci-
sion of a solitary lesion offers the potential of an R0
resection, it is generally advised. Earlier treatment may
also have avoided preoperative radiation. While
advances have been made in approaching the recon-
struction of irradiated tissues [19,20], chest wall resec-
tion and reconstruction (if necessary) would have been
much simpler prior to receiving radiation.
Conclusion
This case highlights the importance of adequately ana-
lyzing the stage of colon cancer (with adequate lymph
node resection) and offering appropriate treatment.
Equally important is the early involvement of a surgeon
in discussing the timing of the treatment for recurrence
and metastasis. Perhaps if the patient had initially
received chemotherapy or earlier resection of the recur-
rence, he could have been spared the forequarter ampu-
tation. The physician must also be aware of the remote
possibility of an unusual presentation of metastasis in
order to pursue timely work up. Fortunately, this patient
is now three years from his amputation and over four
years from his initial sigmoid resection. He continues to
do well with physical therapy and is maintaining close
follow up with no evidence of disease.
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